COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-ImmunologyTM platform, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-ImmunologyTM.